![]() |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Lista de Categorias
AlcoolismoAlzheimer E ParkinsonAnalgésicosAnti-InflamatóriosAnti-helmínticosAnti-viraisAntialérgicosAntibióticosAnticoncepcionaisAnticonvulsivantesAntidepressivosAntifúngicosArtriteAsmaCancroCirúrgiaColesterolCuidados Da PeleCuidados Para Los OjosDiabetesDisfunção EréctilDiuréticosDoenças CardiovascularesEnxaquecasH I VHipertensão ArterialObesidadeOsteoporosePerturbações MentaisPerturbações NeurológicasRelaxantes MuscularesSaúde FemininaSaúde MasculinaTrato GastrointestinalTrato RespiratórioTrato Urinário 27 Apr 2012 13:32:52
Sanofi: Strong performance in Q1 2012 including Genzyme contributionSanofi: Strong performance in Q1 2012 including Genzyme contribution MarketWatch (press release) Sales of Renvela Renagel were euro 147 million, an increase of 8.4% , due to continued US market share growth (US sales were up 18.1% to euro 102 million). At the beginning of April, Sanofi has completed the acquisition of Pluromed Inc., ...
25 Apr 2012 04:50:27
Whoa! These 2 Stocks Beat the Pants Off the Market!Whoa! These 2 Stocks Beat the Pants Off the Market! DailyFinance And with Sanofi's Renagel going off-patent in 2014, there will be a lot more competition to fend off. As we saw with perifosine, nothing's guaranteed till the ink is dry on the approvals. The CAPS community is divided over its future after the failure ...
24 Apr 2012 15:09:13
Keryx Biopharmaceuticals (NASDAQ:KERX) Shares Price And Trade Volume Up After ...Keryx Biopharmaceuticals (NASDAQ:KERX) Shares Price And Trade Volume Up After ... U.S. Election News The company said that both Zerenex and an older drug RenaGel worked for the treatment of high phosphate levels diagnosed in dialysis patients with a kidney disease at its last stage. The study has taken 12 weeks and Keryx's partners Japanese Tobacco ...
23 Apr 2012 20:37:13
Keryx rises as Zerenex succeeds in Japan studyKeryx rises as Zerenex succeeds in Japan study BusinessWeek The company said Zerenex worked as well as an older drug, RenaGel , as a treatment for high phosphate levels in dialysis patients with end-stage kidney disease. The study lasted 12 weeks and was conducted by Keryx's partners Japanese Tobacco Inc. and ...
|
|
Choose Your language:
Pesquisa no site:
Testemunhos
Ao aceder ao e-mail fui direccionado para este link de pesquisa, a que estou a responder agora.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Mais vendidos|Política|Questões Mais Frequentes|Testemunhos|Contacte-nos|Sitemap |
|
|
|
|
| |